Efficacy Signals Of 4-Week Oral DUR-928 in NASH Subjects

被引：0
|
作者：
Lawitz, Eric [1 ]
Hassanein, Tarek [2 ]
Denham, Douglas [3 ]
Waters, Michael [4 ]
Borg, Brian [5 ]
Mille, Gwenaelle [6 ]
Scott, Deborah [6 ]
Miksztal, Andy [6 ]
Culwell, John [6 ]
Ellis, Dave [6 ]
Brown, James [6 ]
Lin, Weiqi [6 ]
机构：
[1] Univ Texas Hlth San Antonio, Texas Liver Inst, San Antonio, TX USA
[2] Southern Calif Res Ctr, Coronado, CA USA
[3] Clin Trials Texas, San Antonio, TX USA
[4] eStudySite, Chula Vista, CA USA
[5] Southern Therapy & Adv Res, Jackson, MS USA
[6] Durect, Cupertino, CA USA
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PO-1198
引用
收藏
页码：S618 / S618
页数：1
相关论文
共 50 条
  • [1] SAFETY AND EFFICACY SIGNALS OF 4-WEEK ORAL DUR-928 IN NASH SUBJECTS
    Lawitz, Eric J.
    Hassanein, Tarek
    Borg, Brian
    Waters, Michael
    Mille, Gwenaelle
    Scott, Deborah
    Miksztal, Andy
    Culwell, John
    Ellis, Dave
    Brown, Jim
    Lin, WeiQi
    HEPATOLOGY, 2020, 72 : 1031 - 1032
  • [2] Safety, Pharmacokinetics, and Efficacy Signals of Larsucosterol (DUR-928) in Alcohol-Associated Hepatitis
    Hassanein, Tarek
    McClain, Craig J.
    Vatsalya, Vatsalya
    Stein, Lance L.
    Flamm, Steven L.
    Martin, Paul
    Cave, Matthew C.
    Mitchell, Mack
    Barton, Bruce
    Nagy, Laura
    Szabo, Gyongyi
    McCullough, Arthur
    Dasarathy, Srinivasin
    Shah, Jaymin
    Blevins, Christina
    Scott, Deborah
    Krebs, William
    Brown, James E.
    Lin, WeiQi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (01): : 107 - 115
  • [3] Safety and pharmacokinetics of DUR-928 in hepatic function impaired subjects
    Shah, Jaymin
    Pozo, Katherine
    Scott, Deborah
    Lin, WeiQi
    JOURNAL OF HEPATOLOGY, 2021, 75 : S613 - S613
  • [4] SAFETY AND EFFICACY OF DUR-928: A POTENTIAL NEW THERAPY FOR ACUTE ALCOHOLIC HEPATITIS
    Hassanein, Tarek
    Stein, Lance L.
    Flamm, Steven L.
    Martin, Paul
    Cave, Matthew C.
    Blevins, Christina
    Scott, Deborah
    Krebs, William
    Lin, WeiQi
    HEPATOLOGY, 2019, 70 (06) : 1483A - 1484A
  • [5] Antiaging efficacy of a combined oral & topical regimen: 4-week clinical investigation
    Kaul, Nalini
    Pagnoni, Alessandra
    Lazer, Wendy
    Mirabella, Steve
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (02) : AB30 - AB30
  • [6] A 4-WEEK ORAL TOXICITY STUDY WITH ACETALDEHYDE AND FORMALDEHYDE IN RATS
    TIL, HP
    WOUTERSEN, RA
    FERON, VJ
    CLARY, JJ
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1987, 9 (01) : 43 - 43
  • [7] Safety assessment of 4-week oral intake of proanthocyanidin-rich grape seed extract in healthy subjects
    Sano, Atsushi
    FOOD AND CHEMICAL TOXICOLOGY, 2017, 108 : 519 - 523
  • [8] Predictors for the Efficacy of 4-Week Dupilumab Treatment in Atopic Dermatitis Patients
    Yu, Ling
    Lian, Cheng
    Li, Linfeng
    Li, Jianguo
    Zhang, Shoumin
    JOURNAL OF ASTHMA AND ALLERGY, 2025, 18 : 331 - 337
  • [9] Evaluation of semisynthetic high-fat diets in development of a 4-week mouse NASH model
    Majstorovic, Ozren
    Antolic, Maja
    Cuzic, Snjezana
    Musak, Lucija
    Cedilak, Matea
    Brzica, Hrvoje
    Bosnar, Martina
    Glojnaric, Ines
    JOURNAL OF HEPATOLOGY, 2022, 77 : S702 - S702
  • [10] 52-week oral gavage chronic toxicity study with ubiquinone in rats with a 4-week recovery
    Williams, KD
    Maneke, JD
    AbdelHameed, M
    Hall, RL
    Palmer, TE
    Kitano, M
    Hidaka, T
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 1999, 47 (09) : 3756 - 3763
12345